Company Description
Genethera (OTC: GTHR) is a publicly traded biological product (except diagnostic) manufacturing company in the Manufacturing sector.
GTHR stock has declined 98.3% over the past year.
This page provides a comprehensive overview of GTHR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Genethera (GTHR) stock. Over the past 12 months, the stock has lost 98.3%.
Latest News
Genethera has 5 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 1 with negative movement. Key topics include covid-19. View all GTHR news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GTHR Company Profile & Sector Positioning
Genethera (GTHR) operates in the Biological Product (except Diagnostic) Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.